SUMMIT THERAPEUTICS INC COM - Stock (SMMT)

CUSIP: 86627R102

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Stock
Total 13F shares
3,449,978
Share change
-693,163
Total reported value
$8,452,000
Price per share
$2.45
Number of holders
14
Value change
-$8,099,737
Number of buys
5
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 86627R102?
CUSIP 86627R102 identifies SMMT - SUMMIT THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q2 2018

As of 30 Jun 2018, SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,449,978 shares. The largest 10 holders included LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., Polar Capital LLP, MORGAN STANLEY, First Eagle Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, and Virtu Financial LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.